Immunization

Novavax’s COVID-19 vaccine has been available in the US under emergency use authorization since July 2022.

Jeff Goad, PharmD, MPH, discusses hepatitis viruses and the current vaccination schedules available for patients to stay protected.

The investigators hope to pursue a human vaccine in order to improve upon the already existing vaccines.

Patients with psychosis, depression, and anxiety exhibit higher rates of vaccine hesitancy.

Brigid Groves, PharmD, MS, Vice President of Professional Affairs at APhA, discusses how the pharmacist’s role in immunization has adapted in recent history.

Vaccination changes serotype distribution from vaccine-type serotypes to nonvaccine-type serotypes.

Shingle vaccination is recommended for adults 50 years and older and for adults 19 years and older who have a weakened immune system due to disease therapy.

A conversation with Greg Mitchell, owner of United Drug Superstore in Hatch, New Mexico, at AAP 2025.

The findings support the need for improved vaccination coverage to prevent the resurgence of previously eliminated infectious diseases in the United States.

In a new survey, approximately one-third of respondents have heard that the MMR vaccine is more dangerous than being infected with the infection.

Investigators specifically analyze information on influenza and pneumococcal vaccinations.

Researchers explore trends from 2014 to 2022 among pediatric invasive pneumococcal diseases since introduction of the 13-valent pneumococcal conjugate vaccine.

Crystal Hodge discusses being transparent about adverse effects of the MMR vaccine and educating patients about measles.

Crystal Hodge discusses R naughts and the measures of how contagious measles is.

The recommendation includes patients 12 years and older traveling to a country where there is a chikungunya outbreak or where there is an elevated risk for US travelers.

Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus.

The FDA approved Penmenvy in February 2025 for use in patients aged 10 to 25 years.

At AAP 2025, Greg Mitchell, owner of United Drug Superstore, discussed how retail pharmacies can leverage vaccine services to build long-term patient relationships.

The designation addresses the unmet need for prevention of H5N1, which remains a global health risk, and a phase 1 trial of the vaccine was initiated in November 2024.

Texas reports over 480 cases of measles and 2 measles-related deaths, with 1 including an unvaccinated pediatric patient.

Previous research shows herpes zoster is associated with a higher long-term risk of subjective cognitive decline, with increased risk for men who carried APOE ε4.

A HealthDay Harris Poll highlights the most recent feelings patients have towards vaccines amid outbreaks of vaccine-preventable illness and changes at the federal level impacting public health policy.

The approval expands the flexibility of storing the vaccine to protect against smallpox events or mpox outbreaks.

In an era of persistent medical misinformation, addressing vaccine hesitancy has become a critical challenge for health care professionals.

Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.